Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nimodipine in Vestibular Schwannoma Resection
NCT04801953Phase 2Unknown
- Sponsor
- Medical University of Vienna
- Start
- May 2021
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nimodipine in vestibular schwannoma (VS), sponsored by Medical University of Vienna. Status: unknown.
02
Drugs
nimodipine
03
Conditions
vestibular schwannoma (VS)
Beyond the preview
Go deeper on NCT04801953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04801953.